Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach.
Female rats were treated for 28 days with high doses of the gastric acid secretion inhibitors omeprazole and ranitidine. Omeprazole, which is long-acting, was given orally once daily. Ranitidine, which is short-acting, was given by continuous infusion (via osmotic minipumps, implanted subcutaneously). The aim was to produce a similar degree of acid inhibition with the two drugs. The inhibition of acid secretion over the day and night was more pronounced in the omeprazole-treated rats (maximal inhibition 100%, minimum 85%) than in those receiving ranitidine (mean 70%). In both groups, there was a great increase in plasma gastrin, somewhat greater after omeprazole than after ranitidine. The gastrin concentration in the antrum was almost doubled by both treatments and there was a moderate increase in the number of antral gastrin cells in the omeprazole-treated rats. The number of enterochromaffin-like (ECL) cells (per visual field) increased in the oxyntic mucosa to the same extent (greater than 100%) in the ranitidine- and omeprazole-treated rats. Apart from the gastrin cells in the antrum and the ECL cells in the corpus no other gastric endocrine cell type seemed to respond to treatments with antisecretagogues. We conclude that, regardless of the type of antisecretagogue used, effective and long-term suppression of gastric acid secretion results in sustained hypergastrinemia and increased number of ECL cells. Conceivably therefore, the ECL cell hyperplasia reflects the trophic effect of gastrin.
AB Hässle, Dept. of Biolopgy, Molndal, Sweden.
B
B
Ryberg
A E
AE
Bishop
S R
SR
Bloom
E
E
Carlsson
R
R
Håkanson
H
H
Larsson
H
H
Mattsson
J M
JM
Polak
F
F
Sundler
D000818:Animals; D002838:Chromaffin System / Q000187:drug effects*; D004759:Enterochromaffin Cells / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000032:analysis / Q000187:drug effects* / Q000473:pathology; D005755:Gastrins / Q000032:analysis; D006632:Histamine / Q000032:analysis; D006640:Histidine Decarboxylase / Q000378:metabolism; D006965:Hyperplasia; D009853:Omeprazole / Q000494:pharmacology*; D011899:Ranitidine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D005755:Gastrins; D006632:Histamine; D011899:Ranitidine; D006640:Histidine Decarboxylase; D009853:Omeprazole